Similar elevations of cytokines associated with type 1 inflammation, including CXCL9, CXCL10, IFN-γ, IL-12, and TNF have been demonstrated at the protein level in serum of IBM patients versus non-myositis controls[11, 34]. This evidence concerns the gene CXCL9 and inclusion body myositis.